DE69829587D1 - Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren - Google Patents

Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren

Info

Publication number
DE69829587D1
DE69829587D1 DE69829587T DE69829587T DE69829587D1 DE 69829587 D1 DE69829587 D1 DE 69829587D1 DE 69829587 T DE69829587 T DE 69829587T DE 69829587 T DE69829587 T DE 69829587T DE 69829587 D1 DE69829587 D1 DE 69829587D1
Authority
DE
Germany
Prior art keywords
nucleic acid
acid molecules
weak
present
phenotypes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69829587T
Other languages
English (en)
Other versions
DE69829587T2 (de
Inventor
A Flegel
F Wagner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DRK Blutspendedienst Baden Wuerttermberg Hessen gGmbH
Original Assignee
Drk Blutspendedienst Bw
DRK Blutspendedienst Baden Wuerttermberg Hessen gGmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231303&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69829587(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Drk Blutspendedienst Bw, DRK Blutspendedienst Baden Wuerttermberg Hessen gGmbH filed Critical Drk Blutspendedienst Bw
Publication of DE69829587D1 publication Critical patent/DE69829587D1/de
Application granted granted Critical
Publication of DE69829587T2 publication Critical patent/DE69829587T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69829587T 1998-01-23 1998-12-18 Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren Expired - Lifetime DE69829587T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98101203 1998-01-23
EP98101203 1998-01-23
PCT/EP1998/008319 WO1999037763A2 (en) 1998-01-23 1998-12-18 Novel nucleic acid molecules correlated with the rhesus weak d phenotype

Publications (2)

Publication Number Publication Date
DE69829587D1 true DE69829587D1 (de) 2005-05-04
DE69829587T2 DE69829587T2 (de) 2006-02-09

Family

ID=8231303

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829587T Expired - Lifetime DE69829587T2 (de) 1998-01-23 1998-12-18 Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren

Country Status (12)

Country Link
US (1) US7005276B1 (de)
EP (1) EP1047777B1 (de)
JP (1) JP2002500884A (de)
AT (1) ATE292176T1 (de)
AU (1) AU748222B2 (de)
BR (1) BRPI9815090B1 (de)
CA (1) CA2318486C (de)
DE (1) DE69829587T2 (de)
ES (1) ES2241195T3 (de)
IL (1) IL137424A0 (de)
PT (1) PT1047777E (de)
WO (1) WO1999037763A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4620920B2 (ja) * 1999-11-02 2011-01-26 デーエルカー ブルーツペンデディーンスト バーデン−ヴュルテンベルク−ヘッセン ゲーゲーエムベーハー Rhd陰性遺伝子座の分子構造
WO2001081621A2 (de) * 2000-04-20 2001-11-01 Adnagen Ag Verfahren, diagnose-kit und mikroarray zur bestimmung des rhesus-faktors
WO2002016396A2 (en) * 2000-08-21 2002-02-28 The New York Blood Center, Inc. Mammalian rh type b glycoprotein ion transporter
US20090186340A1 (en) * 2004-09-22 2009-07-23 University Of The West Of England, Bristol Gene Analysis
EP2118298B1 (de) 2007-02-08 2013-01-09 Sequenom, Inc. Tests auf nukleinsäurebasis für rhd-typisierung
EP3362481A1 (de) * 2015-10-16 2018-08-22 Institut National Transfusion Sanguine Verfahren zur herstellung von erythrozytenproteinen
US11549137B2 (en) 2016-11-23 2023-01-10 Christoph Gassner Determination of the genotype underlying the S-s-U-phenotype of the MNSs blood group system
WO2020113129A1 (en) 2018-11-29 2020-06-04 Polymer Technology Systems, Inc. Systems and methods for electrochemical point-of-care detection of hemoglobin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200802B1 (en) * 1993-10-08 2001-03-13 Arch Development Corporation Human peroxisome proliferator activated receptor gamma: compositions and methods

Also Published As

Publication number Publication date
AU748222B2 (en) 2002-05-30
CA2318486A1 (en) 1999-07-29
EP1047777B1 (de) 2005-03-30
ES2241195T3 (es) 2005-10-16
EP1047777A2 (de) 2000-11-02
IL137424A0 (en) 2001-07-24
PT1047777E (pt) 2005-08-31
BR9815090A (pt) 2000-10-17
WO1999037763A2 (en) 1999-07-29
DE69829587T2 (de) 2006-02-09
WO1999037763A9 (en) 1999-10-28
BRPI9815090B1 (pt) 2016-05-10
JP2002500884A (ja) 2002-01-15
CA2318486C (en) 2010-04-20
AU2274699A (en) 1999-08-09
ATE292176T1 (de) 2005-04-15
WO1999037763A3 (en) 1999-09-16
US7005276B1 (en) 2006-02-28

Similar Documents

Publication Publication Date Title
Jantos-Siwy et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease
JP5244103B2 (ja) 器官特異的蛋白質およびその使用方法
CN102695716B (zh) 肝病病情指标糖链标记物
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
CN104204807B (zh) 用于胃癌的生物标志物及其应用
JP2010500568A5 (de)
CA2131826A1 (en) MN Gene and Protein
DE69938623D1 (de) Microarrays und ihre verwendungen
WO2000050900A3 (en) Methods and compositions for diagnosing carcinomas
WO2007056680A3 (en) Methods and arrays for identifying human microflora
ATE426018T1 (de) Pca3, pca3-gene und verfahren zu ihrer verwendung
DK1734368T3 (da) Annexin-autoantistoffer anvendt som markörer for lungecancer
EP1543331B1 (de) Verfahren zur diagnose von morbus alzheimer
WO2000026668A3 (en) S100 proteins and autoantibodies as serum markers for cancer
DE69829587D1 (de) Nukleinsäuremoleküle, die mit dem schwachen rhesus-d phänotyp korrelieren
CA2274776A1 (en) Method for analyzing annexin v in urine and use thereof
CA2203246A1 (en) Alk-7 (activin like kinase), a serine threonine kinase receptor
WO2009099561A2 (en) Urinary ca125 peptides as biomarkers of ovarian cancer
EP1007570A4 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide
CA2977436A1 (en) Antibody detection method and system
CN111018973B (zh) 一种抗人心肌肌钙蛋白i的重组抗体
WO2006092669A3 (en) Methods of detecting a phenotype of a polymorphic protein
WO2000003687A3 (en) Potassium channel polypeptide and polynucleotide compositions
WO2000070322A3 (en) A-FORM OF CYTOPLASMIC DOMAIN OF nARIA (CRD-NEUREGULIN) AND USES THEREOF
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: DRK-BLUTSPENDEDIENST BADEN-WUERTTEMBERG-HESSEN, DE

8365 Fully valid after opposition proceedings